ACTA1 and non-small cell lung carcinoma: In agreement with these findings, Alcaraz et al. reported that the immunostaining of obtained NSCLC-diagnosed tissues indicated that high expression of α-SMA in CAFs is correlated with a higher risk of recurrence and death in NSCLC patients[57].